| Literature DB >> 32454813 |
Hiroo Imazu1,2, Shiaw-Hooi Ho3, Shoryoku Hino4, Khean-Lee Goh3, Mitsuhiko Moriyama1, Kazuki Sumiyama2, Hisao Tajiri5.
Abstract
BACKGROUND: We developed a novel oblique-tip papillotome (OT-papillotome) to facilitate biliary cannulation during endoscopic retrograde cholangiopancreatography (ERCP). This study was performed to evaluate the utility of the OT-papillotome for contrast-guided cannulation (CGC) and wire-guided cannulation (WGC) during ERCP, compared with standard cannulation by WGC using a standard-tip papillotome (ST-papillotome).Entities:
Year: 2020 PMID: 32454813 PMCID: PMC7229551 DOI: 10.1155/2020/2417841
Source DB: PubMed Journal: Gastroenterol Res Pract ISSN: 1687-6121 Impact factor: 2.260
Figure 1Concept of a new oblique-tip papillotome. A standard-tip papillotome may be advertently aligned with the pancreatic duct (a). The new oblique-tip papillotome can deflect the interposed septum between the opening of the common bile duct and the pancreatic duct below. As a result, the top of the oblique-tip papillotome can follow a course toward the bile duct (b). The new oblique-tip papillotome with cutting wire, injection, and guide wire lumen. The tip of the oblique-tip papillotome is sharpened obliquely and circumferentially and is angled at approximately 40 degrees (c). CBD: common bile duct; MPD: main pancreatic duct.
Patient characteristics in the unmatched cohort.
| OT-CGC | OT-WGC | ST-WGC | |
|---|---|---|---|
| Number of patients | 80 | 80 | 80 |
| Age | 67.793 ± 12.1021,4 | 58.65 ± 17.979 | 58.086 ± 18.926 |
| Sex (male/female) | 48/32 | 36/44 | 37/43 |
| Underlying disease (benign/malignant) | 47/332,5 | 69/11 | 65/15 |
| Choledocolithiasis | 41 | 57 | 51 |
| Other benign disease | 6 | 12 | 14 |
| Pancreatic cancer | 10 | 3 | 7 |
| Biliary cancer | 14 | 6 | 8 |
| Other malignancy | 9 | 2 | 0 |
| Diverticulum (-/+) | 70/10 | 76/4 | 77/3 |
| Endoscopic procedure (ERC/EBD/EST) | 15/53/12 | 1/20/593 | 18/27/35 |
ERC: endoscopic retrograde cholangiography; EBD: endoscopic biliary drainage; EST: endoscopic sphincterotomy. 1p = 0.0001 (OT-CGC vs. ST-WGC), 2p = 0.0019 (OT-CGC vs. ST-WGC), 3p = 0.001 (OT-WGC vs. ST-WGC), 4p = 0.0001 (OT-CGC vs. OT-WGC), and 5p = 0.0002 (OT-CGC vs. OT-WGC).
Outcomes of biliary cannulation in the unmatched cohort.
| OT-CGC |
| OT-WGC |
| ST-WGC | |
|---|---|---|---|---|---|
| Number of unintended pancreatic access events | 1.235 ± 1.925 | 0.135 | 1.162 ± 1.831 | 0.214 | 0.825 ± 1.581 |
| Biliary cannulation time (seconds) | 318.353 ± 535.386 | 0.045 | 434.684 ± 486.727 | 0.499 | 490.691 ± 514.384 |
| Frequency of rescue cannulation (%) | 13.75 (11/80) | 0.001 | 20 (16/80) | 0.022 | 36.25 (29/80) |
| Successful biliary cannulation rate (%) | 97.5 (78/80) | 0.002 | 98.75 (79/1) | 0.002 | 83.75 (67/80) |
| Incidence of PEP (%) | 5 (4/80) | 1.0 | 5 (4/80) | 1.0 | 6.25 (5/80) |
Multivariate regression models: factors associated with the biliary cannulation time, number of unintended pancreatic access events, frequency of rescue cannulation, biliary cannulation rate, and incidence of PEP.
| Coefficient or odds ratio (95% CI) |
| |
|---|---|---|
| Objective variable: number of unintended pancreatic access events | ||
| OT-papillotome (vs. ST-papillotome) | 1.579 (0.825-3.023) | 0.168 |
| Age | 1.003 (0.987-1.019) | 0.735 |
| Male (vs. female) | 0.555 (0.328-0.9388) | 0.028 |
| Malignancy (vs. benign disease) | 0.783 (0.403-1.522) | 0.470 |
| Diverticulum (vs. no diverticulum) | 0.619 (0.22-1.745) | 0.364 |
| Wire-guided cannulation (vs. contrast-guided) | 0.781 (0.408-1.499) | 0.458 |
| Objective variable: biliary cannulation time | ||
| OT-papillotome (vs. ST-papillotome) | -62.915 (-231.882-106.053) | 0.464 |
| Age | 1.779 (-2.435-5.994) | 0.406 |
| Male (vs. female) | -18.156 (-154.931-118.618) | 0.794 |
| Malignancy (vs. benign disease) | 54.622 (-115.241-224.484) | 0.527 |
| Diverticulum (vs. no diverticulum) | -138.70 (-414.775-137.376) | 0.323 |
| Wire-guided cannulation (vs. contrast-guided) | 131.248 (-40.312-302.807) | 0.133 |
| Objective variable: frequency of rescue cannulation | ||
| OT-papillotome (vs. ST-papillotome) | 0.447 (0.2185-0.916) | 0.028 |
| Age | 0.991 (0.973-1.009) | 0.311 |
| Male (vs. female) | 0.850 (0.462-1.564) | 0.601 |
| Malignancy (vs. benign disease) | 1.596 (0.760-3.354) | 0.217 |
| Diverticulum (vs. no diverticulum) | 1.079 (0.321-3.627) | 0.902 |
| Wire-guided cannulation (vs. contrast-guided) | 1.127 (0.491-2.583) | 0.778 |
| Objective variable: incidence of PEP | ||
| OT-papillotome (vs. ST-papillotome) | 0.791 (0.203-3.080) | 0.735 |
| Age | 0.992 (0.959-1.026) | 0.633 |
| Male (vs. female) | 0.486 (0.153-1.550) | 0.223 |
| Malignancy (vs. benign disease) | 1.471 (0.385-5.622) | 0.572 |
| Diverticulum (vs. no diverticulum) | 0.984 (0.110-8.839) | 0.989 |
| Wire-guided cannulation (vs. contrast-guided) | 0.779 (0.180-3.361) | 0.738 |
| Objective variable: successful biliary cannulation | ||
| OT-papillotome (vs. ST-papillotome) | 21.906 (2.401-199.864) | 0.006 |
| Age | 1.002 (0.966-1.040) | 0.895 |
| Male (vs. female) | 3.318 (0.904-12.178) | 0.071 |
| Malignant (vs. benign disease) | 0.253 (0.061-1.046) | 0.058 |
| Diverticulum (vs. no diverticulum) | 0.056 (0.008-0.408) | 0.004 |
| Wire-guided cannulation (vs. contrast-guided) | 0.924 (0.071-12.097) | 0.952 |
Comparison of cannulation outcomes in the OT-CGC and ST-WGC groups by coarsened exact matching.
| OT-CGC ( | ST-WGC ( | OR or coefficient (95% CI) |
| Statistical method | |
|---|---|---|---|---|---|
| Number of unintended pancreatic access | 1.26 ± 1.92 | 0.88 ± 1.73 | 1.94 (0.966-3.884) | 0.063 | Ordinal logistic regression |
| Time to biliary cannulation (second) | 321.9 ± 539.7 | 488.1 ± 534.2 | -166.2 (-360.212-27.750) | 0.092 | Linear regression |
| Frequency of the use of rescue cannulation method (%) | 18.7% (13/75) | 42.3% (29/68) | 0.29 (0.135-0.627) | 0.002 | Logistic regression |
| Successful biliary cannulation rate (%) | 98.7% (74/75) | 74.6% (51/68) | 25.13 (3.24-194.732) | 0.002 | Logistic regression |
| Incidence of PEP (%) | 5.3% (4/75) | 5.8% (4/68) | 0.92 (0.219-3.830) | 0.904 | Logistic regression |
Comparison of cannulation outcomes in the OT-WGC and ST-WGC groups by coarsened exact matching.
| OT-WGC ( | ST-WGC ( | OR or coefficient (95% CI) |
| Statistical method | |
|---|---|---|---|---|---|
| Number of unintended pancreatic access events | 1.24 ± 1.87 | 0.76 ± 1.46 | 1.80 (0.924-3.496) | 0.084 | Ordinal logistic regression |
| Biliary cannulation time (seconds) | 450.6 ± 494.2 | 596.6 ± 624.1 | -145.9 (-337.064-45.123) | 0.133 | Linear regression |
| Frequency of rescue cannulation (%) | 21.3% (16/75) | 44.1% (32/73) | 0.34 (0.167-0.706) | 0.004 | Logistic regression |
| Successful biliary cannulation rate (%) | 100% (75/75) | 80.8% (59/73) | N/A | 0.002 | Chi-square |
| Incidence of PEP (%) | 4% (3/75) | 6.2% (4.5/73) | 0.63 (0.141-2.817) | 0.546 | Logistic regression |
Comparison of cannulation outcomes in the OT-WGC and OT-CGC groups by coarsened exact matching.
| OT-WGC ( | OT-CGC ( | OR or coefficient (95% CI) |
| Statistical method | |
|---|---|---|---|---|---|
| Number of unintended pancreatic access events | 1.24 ± 1.91 | 1.89 ± 2.28 | 0.514 (0.274-0.165) | 0.038 | Ordinal logistic regression |
| Biliary cannulation time (seconds) | 457.9 ± 509.0 | 344.0 ± 513.1 | 113.8 (-58.657-286.356) | 0.194 | Linear regression |
| Frequency of rescue cannulation (%) | 22.4% (15/67) | 24.1% (18/74) | 0.89 (0.406-1.949) | 0.77 | Logistic regression |
| Successful biliary cannulation rate (%) | 98.5% (66/67) | 96.8% (72/74) | 2.21 (0.209-23.305) | 0.51 | Logistic regression |
| Incidence of PEP (%) | 3% (2/67) | 8.7% (6/74) | 0.31 (0.062-1.597) | 0.163 | Logistic regression |